Yes, I am well aware of all of this. But this report indicates that PLS, shouldn't face insolvency, be forced to use a CR, or go begging to the Chinese (CATL) for help in the next 12-18 months, which is a huge deal. That was my primary concern with this company. Now, it looks like PLS might be well positioned to take off if spodumene prices return to a sane level in FY 2021/2022. Almost inclined to change sentiment to buy.
Ann: Quarterly Activities Report, page-11
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.16 |
Change
0.170(5.69%) |
Mkt cap ! $9.515B | |||
| Open | High | Low | Value | Volume |
| $3.10 | $3.20 | $3.05 | $117.6M | 37.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 72180 | $3.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.17 | 222212 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PLS (ASX) Chart |